A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment

Aim: To elicit patients’ preferences for HIV/AIDS treatment characteristics in Colombia. Materials and methods: A best–worst scaling case was used to provide a ranking of 26 HIV/AIDS treatment characteristics that were similar to a previous study conducted in Germany. In each choice task, participan...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22393
Acceso en línea:
https://doi.org/10.1080/13696998.2018.1440401
https://repository.urosario.edu.co/handle/10336/22393
Palabra clave:
Antiretrovirus agent
Antiretrovirus agent
Acquired immune deficiency syndrome
Adult
Alcohol consumption
Antiretroviral therapy
Article
Best worst scaling
Clinical assessment
Clinical effectiveness
Colombian
Comorbidity
Diagnostic test
Disease duration
Domestic violence
Female
Heterosexuality
Homosexuality
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
Life expectancy
Major clinical study
Male
Methodology
Self concept
Sexual education
Sexuality
Social behavior
Treatment duration
Acquired immune deficiency syndrome
Age
Bayes theorem
Colombia
Decision making
Drug administration
Educational status
Health behavior
Human immunodeficiency virus infection
Middle aged
Patient preference
Severity of illness index
Sex factor
Socioeconomics
Acquired immunodeficiency syndrome
Adult
Age factors
Anti-retroviral agents
Bayes theorem
Choice behavior
Colombia
Decision making
Drug administration schedule
Educational status
Health behavior
Hiv infections
Humans
Life expectancy
Male
Middle aged
Patient preference
Severity of illness index
Sex factors
Socioeconomic factors
Aids
Best-worst scaling
Hiv
Patient preferences
Transferability
Treatment
Rights
License
Abierto (Texto Completo)
id EDOCUR2_c9555aff40408dc21698fcad71429652
oai_identifier_str oai:repository.urosario.edu.co:10336/22393
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling d518dd69-192e-4730-9ed2-c263d1684828d27de9a1-69ed-4f0f-81a2-60ba435836d30a1d62d9-de1a-410d-92a7-4129dd6d64726841b6b8-d7f2-41fd-a4d8-e017407b0d6c67b1beef-72e7-489e-afca-c28f8d2f048a6758056600f3063591-dc50-4b3a-a1db-7f6ef4aed081522eaf90-589d-4808-8bb9-328af2698c102f4b23a2-ead8-4ee3-ab1e-1eca7b2703592020-05-25T23:56:19Z2020-05-25T23:56:19Z2018Aim: To elicit patients’ preferences for HIV/AIDS treatment characteristics in Colombia. Materials and methods: A best–worst scaling case was used to provide a ranking of 26 HIV/AIDS treatment characteristics that were similar to a previous study conducted in Germany. In each choice task, participants were asked to choose the most important and the least important treatment characteristics from a set of five from the master list. Using the Hierarchical Bayes method, relative importance scores were calculated. Sub-group analyses were conducted according to sex, education, source of infection, symptoms, and age. Results: A total of 195 patients fully completed the questionnaire. The three most important characteristics were “drug has very high efficacy” (relative importance score [RIS] = 10.1), “maximum prolongation of life expectancy” (RIS = 9.7), and “long duration of efficacy” (RIS = 7.4). Sub-group analysis showed only three significant (but minor) differences between older and younger people. Conclusion: This study suggests that treatment characteristics regarding efficacy and prolongation of life are particularly important for patients in Colombia. Further investigation on how patients make trade-offs between these important characteristics and incorporating this information in clinical and policy decision-making would be needed to improve adherence with HIV/AIDS medication. © 2018 Informa UK Limited, trading as Taylor and Francis Group.application/pdfhttps://doi.org/10.1080/13696998.2018.144040113696998https://repository.urosario.edu.co/handle/10336/22393engTaylor and Francis Ltd473No. 5468Journal of Medical EconomicsVol. 21Journal of Medical Economics, ISSN:13696998, Vol.21, No.5 (2018); pp. 468-473https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042927545&doi=10.1080%2f13696998.2018.1440401&partnerID=40&md5=e2c2c0cde953abf203e2e967ceda321dAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAntiretrovirus agentAntiretrovirus agentAcquired immune deficiency syndromeAdultAlcohol consumptionAntiretroviral therapyArticleBest worst scalingClinical assessmentClinical effectivenessColombianComorbidityDiagnostic testDisease durationDomestic violenceFemaleHeterosexualityHomosexualityHumanHuman immunodeficiency virus infected patientHuman immunodeficiency virus infectionLife expectancyMajor clinical studyMaleMethodologySelf conceptSexual educationSexualitySocial behaviorTreatment durationAcquired immune deficiency syndromeAgeBayes theoremColombiaDecision makingDrug administrationEducational statusHealth behaviorHuman immunodeficiency virus infectionMiddle agedPatient preferenceSeverity of illness indexSex factorSocioeconomicsAcquired immunodeficiency syndromeAdultAge factorsAnti-retroviral agentsBayes theoremChoice behaviorColombiaDecision makingDrug administration scheduleEducational statusHealth behaviorHiv infectionsHumansLife expectancyMaleMiddle agedPatient preferenceSeverity of illness indexSex factorsSocioeconomic factorsAidsBest-worst scalingHivPatient preferencesTransferabilityTreatmentA best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatmentarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Hendriks A.Wijnen B.van Engelen R.Conde R.Evers S.M.González Rodríguez, Javier LeonardoGovers M.Mühlbacher A.Hiligsmann M.10336/22393oai:repository.urosario.edu.co:10336/223932022-05-02 07:37:16.20158https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
title A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
spellingShingle A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
Antiretrovirus agent
Antiretrovirus agent
Acquired immune deficiency syndrome
Adult
Alcohol consumption
Antiretroviral therapy
Article
Best worst scaling
Clinical assessment
Clinical effectiveness
Colombian
Comorbidity
Diagnostic test
Disease duration
Domestic violence
Female
Heterosexuality
Homosexuality
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
Life expectancy
Major clinical study
Male
Methodology
Self concept
Sexual education
Sexuality
Social behavior
Treatment duration
Acquired immune deficiency syndrome
Age
Bayes theorem
Colombia
Decision making
Drug administration
Educational status
Health behavior
Human immunodeficiency virus infection
Middle aged
Patient preference
Severity of illness index
Sex factor
Socioeconomics
Acquired immunodeficiency syndrome
Adult
Age factors
Anti-retroviral agents
Bayes theorem
Choice behavior
Colombia
Decision making
Drug administration schedule
Educational status
Health behavior
Hiv infections
Humans
Life expectancy
Male
Middle aged
Patient preference
Severity of illness index
Sex factors
Socioeconomic factors
Aids
Best-worst scaling
Hiv
Patient preferences
Transferability
Treatment
title_short A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
title_full A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
title_fullStr A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
title_full_unstemmed A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
title_sort A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
dc.subject.keyword.spa.fl_str_mv Antiretrovirus agent
Antiretrovirus agent
Acquired immune deficiency syndrome
Adult
Alcohol consumption
Antiretroviral therapy
Article
Best worst scaling
Clinical assessment
Clinical effectiveness
Colombian
Comorbidity
Diagnostic test
Disease duration
Domestic violence
Female
Heterosexuality
Homosexuality
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
Life expectancy
Major clinical study
Male
Methodology
Self concept
Sexual education
Sexuality
Social behavior
Treatment duration
Acquired immune deficiency syndrome
Age
Bayes theorem
Colombia
Decision making
Drug administration
Educational status
Health behavior
Human immunodeficiency virus infection
Middle aged
Patient preference
Severity of illness index
Sex factor
Socioeconomics
Acquired immunodeficiency syndrome
Adult
Age factors
Anti-retroviral agents
Bayes theorem
Choice behavior
Colombia
Decision making
Drug administration schedule
Educational status
Health behavior
Hiv infections
Humans
Life expectancy
Male
Middle aged
Patient preference
Severity of illness index
Sex factors
Socioeconomic factors
Aids
Best-worst scaling
Hiv
Patient preferences
Transferability
Treatment
topic Antiretrovirus agent
Antiretrovirus agent
Acquired immune deficiency syndrome
Adult
Alcohol consumption
Antiretroviral therapy
Article
Best worst scaling
Clinical assessment
Clinical effectiveness
Colombian
Comorbidity
Diagnostic test
Disease duration
Domestic violence
Female
Heterosexuality
Homosexuality
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
Life expectancy
Major clinical study
Male
Methodology
Self concept
Sexual education
Sexuality
Social behavior
Treatment duration
Acquired immune deficiency syndrome
Age
Bayes theorem
Colombia
Decision making
Drug administration
Educational status
Health behavior
Human immunodeficiency virus infection
Middle aged
Patient preference
Severity of illness index
Sex factor
Socioeconomics
Acquired immunodeficiency syndrome
Adult
Age factors
Anti-retroviral agents
Bayes theorem
Choice behavior
Colombia
Decision making
Drug administration schedule
Educational status
Health behavior
Hiv infections
Humans
Life expectancy
Male
Middle aged
Patient preference
Severity of illness index
Sex factors
Socioeconomic factors
Aids
Best-worst scaling
Hiv
Patient preferences
Transferability
Treatment
description Aim: To elicit patients’ preferences for HIV/AIDS treatment characteristics in Colombia. Materials and methods: A best–worst scaling case was used to provide a ranking of 26 HIV/AIDS treatment characteristics that were similar to a previous study conducted in Germany. In each choice task, participants were asked to choose the most important and the least important treatment characteristics from a set of five from the master list. Using the Hierarchical Bayes method, relative importance scores were calculated. Sub-group analyses were conducted according to sex, education, source of infection, symptoms, and age. Results: A total of 195 patients fully completed the questionnaire. The three most important characteristics were “drug has very high efficacy” (relative importance score [RIS] = 10.1), “maximum prolongation of life expectancy” (RIS = 9.7), and “long duration of efficacy” (RIS = 7.4). Sub-group analysis showed only three significant (but minor) differences between older and younger people. Conclusion: This study suggests that treatment characteristics regarding efficacy and prolongation of life are particularly important for patients in Colombia. Further investigation on how patients make trade-offs between these important characteristics and incorporating this information in clinical and policy decision-making would be needed to improve adherence with HIV/AIDS medication. © 2018 Informa UK Limited, trading as Taylor and Francis Group.
publishDate 2018
dc.date.created.spa.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:56:19Z
dc.date.available.none.fl_str_mv 2020-05-25T23:56:19Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1080/13696998.2018.1440401
dc.identifier.issn.none.fl_str_mv 13696998
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22393
url https://doi.org/10.1080/13696998.2018.1440401
https://repository.urosario.edu.co/handle/10336/22393
identifier_str_mv 13696998
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 473
dc.relation.citationIssue.none.fl_str_mv No. 5
dc.relation.citationStartPage.none.fl_str_mv 468
dc.relation.citationTitle.none.fl_str_mv Journal of Medical Economics
dc.relation.citationVolume.none.fl_str_mv Vol. 21
dc.relation.ispartof.spa.fl_str_mv Journal of Medical Economics, ISSN:13696998, Vol.21, No.5 (2018); pp. 468-473
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042927545&doi=10.1080%2f13696998.2018.1440401&partnerID=40&md5=e2c2c0cde953abf203e2e967ceda321d
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Taylor and Francis Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167655511228416